Evaluating the effect of astaxanthin supplement on the levels of trace elements in patients with type 2 diabetes treated with metformi

Phase 3

• Conditions: Type 2 Diabetes.; Type 2 diabetes mellitus

• Registration Number: IRCT20190305042939N3
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients with type 2 diabetesTreated by metformin
Age: 20-60 years

Exclusion Criteria

Patients with type 1 diabetes
Pregnant women
Women in lactation
Taking any anti diabetic drug other than metformin
Patients with other endocrine disorders
Take any other antioxidant supplement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cellular levels of magnesium. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Cellular levels of zinc. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Cellular levels of copper. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Cellular levels of selenium. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.

Secondary Outcome Measures

Name	Time	Method
Plasma levels of magnesium. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Plasma levels of Zinc. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Plasma levels of copper. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.;Plasma levels of selenium. Timepoint: Before and at the end of intervention. Method of measurement: Atomic absorption analysis.